Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for S&S Healthcare Holding Ltd. (4198:TWSE), powered by AI.
S&S Healthcare Holding Ltd. is currently trading at $38.20. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for S&S Healthcare Holding Ltd. on Alpha Lenz.
View S&S Healthcare Holding Ltd.'s valuation metrics on Alpha Lenz.
“S&S Healthcare Holding Ltd.'s ROE is -19.4%. Explore profitability and growth together.”
Ask for details →S&S Healthcare Holding Ltd. is an investment holding company specializing in the healthcare equipment industry, with a strong emphasis on advanced medical imaging technologies and related services. The company develops, manufactures, and markets digital X-ray diagnostic imaging equipment, bone density measurement systems, and provides installation, repair, and maintenance solutions for magnetic resonance imaging equipment. S&S Healthcare Holding Ltd. plays a crucial role within the global medical device sector, offering patented technologies and certified solutions for hospitals, clinics, and imaging centers. Its business operations span North America, Europe, and Asia, maintaining a robust marketing and customer service network that supports both product sales and after-market support. The company’s primary market segment includes healthcare facilities seeking reliable, state-of-the-art medical imaging and diagnostic platforms. S&S Healthcare Holding Ltd. has built international brand visibility and leverages its expertise to participate in global tenders, reinforcing its position as a key player in the health care equipment field and contributing to advancements in diagnostic accuracy and patient care.
“S&S Healthcare Holding Ltd.'s ROE is -19.4%. Explore profitability and growth together.”
Ask for details →S&S Healthcare Holding Ltd. (ticker: 4198) is a company listed on TWSE in the Healthcare sector (Medical Devices).
The current price is 38.2 with a P/E ratio of -x and P/B of -x.
ROE is -19.41% and operating margin is -23.13%. Annual revenue is $204M.